Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin

Journal of Pharmaceutical Sciences

Volumn 103, Issue 8, 2014, Pages 2484-2497

  Kuo, Yung Chih ^a   Chou, Pei Ru ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; blood brain barrier; CNS; liposome; neuron growth factor; permeability; RMP 7; targeted drug delivery; transferrin; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; LIPOSOME; LOBRADIMIL; NERVE GROWTH FACTOR; PROPIDIUM IODIDE; TRANSFERRIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BRADYKININ; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BRAIN CELL; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; ELECTRIC RESISTANCE; ENCAPSULATION; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; NERVE CELL DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN CROSS LINKING; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; BRAIN; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; VASCULARIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ASTROCYTES; BRADYKININ; BRAIN; CELL LINE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; LIPOSOMES; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; TRANSFERRIN;

EID: 84905080443     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24081     Document Type: Article

References (74)

1. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR,. 1995. An english translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde ". Clin Anat 8 (6): 429-431.
2. Thies W, Bleiler L,. 2013. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9 (2): 208-245.
3. Duyckaerts C, Delatour B, Potier MC,. 2009. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118 (1): 5-36.
4. Turner PR, O'Connor K, Tate WP, Abraham WC,. 2003. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70 (1): 1-32.
5. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS,. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38 (11): 3751-3757.
6. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY,. 2002. Intracellular accumulation of β-amyloid(1-42) in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110 (2): 199-211.
7. Shaykhalishahi H, Taghizadeh M, Yazdanparast R, Chang YT,. 2010. Anti-amyloidogenic effect of AA3E2 attenuates beta-amyloid induced toxicity in SK-N-MC cells. Chem Biol Interact 186 (1): 16-23.
8. Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM,. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 172 (11): 7078-7085.
9. Tsuruda A, Suzuki S, Maekawa T, Oka S,. 2004. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells. FEBS Lett 560 (1-3): 215-220.
10. Vemuri S, Rhodes CT,. 1995. Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharm Acta Helv 70 (2): 95-111.
11. Gabizon A, Goren D, Horowitz AT, Tzemach D, Lossos A, Siegal T,. 1997. Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev 24 (2-3): 337-344.
12. Tamaru M, Akita H, Fujiwara T, Kajimoto K, Harashima H,. 2010. Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. Biochem Biophys Res Commun 394 (3): 587-592.
13. Ivankin A, Kuzmenko I, Gidalevitz D,. 2010. Cholesterol-phospholipid interactions: New insights from surface x-ray scattering data. Phys Rev Lett 104 (10): 108101.
14. Bartus RT, Elliott PJ, Hayward NJ, Deen RL, Fisher SK,. 1996. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33 (1-3): 270-278.
15. Straub JA, Akiyama A, Parmar P,. 1994. In vitro plasma metabolism of RMP-7. Pharm Res 11 (11): 1673-1676.
16. Emerich DF, Dean RL, Marsh J, Pink M, Lafreniere D, Snodgrass P, Bartus RT,. 2000. Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Pharm Res 17 (10): 1212-1219.
17. Voinea M, Dragomir E, Manduteanu I, Simionescu M,. 2002. Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells. Vascul Pharmacol 39 (1-2): 13-20.
18. Gan CW, Feng SS,. 2010. Transferrin-conjugated nanoparticles of poly(lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 31 (30): 7748-7757.
19. Shah N, Chaudhari K, Dantuluri P, Murthy RSR, Das S,. 2009. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target 17 (7): 533-542.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (6): 3440-3450.
21. Kuo YC, Lu CH,. 2011. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. Colloids Surf B 86 (1): 225-231.
22. Soni V, Kohli DV, Jain SK,. 2005. Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target 13 (4): 245-250.
23. Zhong ZR, Zhang ZR, Liu J, Deng Y, Zhang HW, Fu Y, Song QG, He Q,. 2007. Characteristics comparison before and after lyophilization of transferrin modified procationic-liposome-protamine-DNA complexes (Tf-PLPD). Arch Pharm Res 30 (1): 102-108.
24. Zhong ZR, Zhang ZR, Liu J, Deng Y, Zhang HW, Fu Y, Song QG, He Q,. 2007. Characterization of transferring-modified procationic-liposome-protamine-DNA complexes. J Pharm Soc Jpn 127 (3): 533-539.
25. Wileya DT, Websterb O, Galea A, Davis ME,. 2013. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci USA 110 (21): 8662-8667.
26. Tirosh B, Khatib N, Barenholz Y, Nissan A, Rubinstein A,. 2009. Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa. Mol Pharm 6 (4): 1083-1091.
27. Simoes S, Slepushkin V, Gaspar R, Pedroso de Lima MC, Duzgunes N,. 1998. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther 5 (7): 955-964.
28. Oliveira AC, Ferraz MP, Monteiro FJ, Simoes S,. 2009. Cationic liposome-DNA complexes as gene delivery vectors: Development and behaviour towards bone-like cells. Acta Biomater 5 (6): 2142-2151.
29. Muthu MS, Kulkarni SA, Raju A, Feng SS,. 2012. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33 (12): 3494-3501.
30. Atyabi F, Farkhondehfal A, Esmaeili F, Dinarvand R,. 2009. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice. Acta Pharm 59 (2): 133-144.
31. Joo SY, Kim JS,. 2002. Enhancement of gene transfer to cervical cancer cells using transferrin-conjugated liposome. Drug Dev Ind Pharm 28 (8): 1023-1031.
32. Li P, Chen S, Jiang Y, Jiang J, Zhang Z, Sun X,. 2013. Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine. Nanotechnology 24 (29): 1-12.
33. Paszko E, Vaz GMF, Ehrhardt C, Senge MO,. 2013. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer. Eur J Pharm Sci 48 (1-2): 202-210.
34. Derycke ASL, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, Huwyler J, Missiaen L, de Witte PAM,. 2004. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst 96 (21): 1620-1630.
35. Fonseca C, Moreira JN, Ciudad CJ, de Lima MCP, Simoes S,. 2005. Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells. Eur J Pharm Biopharm 59 (2): 359-366.
36. Sharma G, Modgil A, Sun C, Singh J,. 2012. Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model. J Pharm Sci 101 (7): 2468-2478.
37. Gijsens A, Derycke A, Missianen L, De Vos D, Huwyler J, Eberle A, de Witte P,. 2002. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int J Cancer 101 (1): 78-85.
38. Lu J, Jeon E, Lee BS, Onyuksel H, Wang ZJ,. 2006. Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes. J Control Release 110 (3): 505-513.
39. Moreira JN, Ishida T, Gaspar R, Allen TM,. 2002. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res 19 (3): 265-269.
40. Stins MF, Gilles F, Kim KS,. 2010. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76 (1-2): 81-90.
41. Matyash V, Kettenmann H,. 2010. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 63 (1-2): 2-10.
42. Tiewcharoen S, Rabablert J, Chetanachan P, Junnu V, Worawirounwong D, Malainual N,. 2008. Scanning electron microscopic study of human neuroblastoma cells affected with Naegleria fowleri Thai strains. Parasitol Res 103 (5): 1119-1123.
43. Avgerropoulos NG, Batchelor TT,. 1999. New treatment strategies for malignant gliomas. Oncologist 4 (3): 209-224.
44. Prados MD, Schold SJS, Fine HA, Jaeckle K, Hochberg F, Mechtler L, Fetell MR, Phuphanich S, Feun L, Janus TJ, Ford K, Graney W,. 2003. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncolo 5 (2): 96-103.
45. Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK,. 1996. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33 (1-3): 270-278.
46. Doctrow SR, Abelleira SM, Curry LA, Heller-Harrison R, Kozarich JW, Malfroy B, Mccarroll LA, Morgan KG, Morrow AR, Musso GF, Smart JL, Straub JA, Turnbull B, Gloff CA,. 1994. The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J Pharmacol Exp Ther 271: 229-237.
47. Schwaninger M, Schwaninger M, Sallmann S, Petersen N, Schneider A, Prinz S, Libermann TA, Spranger M,. 1999. Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-KB. J Neurochem 73 (4): 1461-1466.
48. Kim D, Cho SH, Kim JS, Jo SH, Lee SJ, Kim KT, Choi SY,. 2010. Human astrocytic bradykinin B(2) receptor modulates zymosan-induced cytokine expression in 1321N1 cells. Peptides 31 (1): 101-107.
49. Braet K, Paemeleire K, D'Herde K, Sanderson MJ, Leybaert L,. 2001. Astrocyte-endothelial cell calcium signals conveyed by two signalling pathways. Eur J Neurosci 13 (1): 79-91.
50. Cui Y, Xu Q, Chow PK, Wang D, Wang CH,. 2013. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34 (33): 8511-8520.
51. Moos T, Morgan EH,. 2000. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20 (1): 77-95.
52. Du F, Qian C, Qian ZM, Wu XM, Xie H, Yung WH, Ke Y,. 2011. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase a pathway. Glia 59 (6): 936-945.
53. Pelizzoni I, Zacchetti D, Campanella A, Grohovaz F, Codazzi F,. 2013. Iron uptake in quiescent and inflammation-activated astrocytes: A potentially neuroprotective control of iron burden. Biochim Biophys Acta 1832 (8): 1326-1333.
54. Yang L, Fan M, Du F, Gong Q, Bi ZG, Zhu ZJ, Zhu LL, Ke Y,. 2012. Hypoxic preconditioning increases iron transport rate in astrocytes. Biochim Biophys Acta 1822 (4): 500-508.
55. Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T, Hou X,. 2005. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: In vitro and in vivo studies. J Control Release 105 (1-2): 106-119.
56. Wu S, Li G, Li X, Lin C, Yu D, Luan S, Ma C,. 2014. Transport of glial cell line-derived neurotrophic factor into liposomes across the blood-brain barrier: In vitro and in vivo studies. Int J Mol Sci 15 (3): 3612-3623.
57. Mackic JB, Stin M, Jovanovic S, Kim KS, Bartus RT, Zlokovic BV,. 1999. Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers. Pharm Res 16 (9): 1360-1365.
58. 2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation. Ultrasound Med Biol 36 (7): 1176-1187.
59. Wilson-Ashworth HA, Judd AM, Law RM, Freestone BD, Taylor S, Mizukawa MK, Cromar JR, Sudweeks S, Bell JD,. 2004. Formation of transient non-protein calcium pores by lysophospholipids in S49 lymphoma cells. J Membr Biol 200 (1): 25-33.
60. Ding H, Sagar V, Agudelo M, Pilakka-Kanthikeel S, Atluri VSR, Raymond A, Samikkannu T, Nair MP,. 2014. Enhanced blood-brain barrier transmigration using a novel transferring embedded fluorescent magneto-liposome nanoformulation. Nanotechnology 25 (5): 055101.
61. Sanovich E, Bartus RT, Friden PM, Dean RL, Le HQ, Brightman MW,. 1995. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res 705 (1-2): 125-135.
62. Laakkonen JP, Engler T, Romero IA, Weksler B, Couraud PO, Kreppel F, Kochanek S,. 2012. Transcellular targeting of fiber- and hexon-modified adenovirus vectors across the brain microvascular endothelial cells in vitro. PLoS One 7 (9): e45977.
63. Markoutsa E, Pampalakis G, Niarakis A, Romero IA, Weksler B, Couraud PO, Antimisiaris SG,. 2011. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur J Pharm Biopharm 77 (2): 265-274.
64. Giunta S, Galeazzi R, Valli MB, Corder EH, Galeazzi L,. 2004. Transferrin neutralization of amyloid β-25-35 cytotoxicity. Clin Chim Acta 350 (1-2): 129-136.
65. Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ,. 2007. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci 10 (3): 350-357.
66. Liu LB, Xue YX, Liu YH,. 2010. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway. J Neurooncol 99 (2): 187-194.
67. Zhang X, Xie Y, Jin Y, Hou X, Ye L, Lou J,. 2004. The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain. Drug Deliv 11 (5): 301-309.
68. Kuo YC, Lee CY,. 2012. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier. Colloids Surf B 90 (8): 75-82.
69. Canovi M, Markoutsa E, Lazar AN, Pampalakis G, Clemente C, Re F, Sesana S, Masserini M, Salmona M, Duyckaerts C, Flores O, Gobbi M, Antimisiaris SG,. 2011. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 32 (23): 5489-5497.
70. Bereczki E, Re F, Masserini ME, Winblad B, Pei JJ,. 2011. Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells. Nanomedicine 7 (5): 560-571.
71. Brambilla D, Verpillot R, De Kimpe L, Taverna M, Le Droumaguet B, Nicolas J, Canovi M, Gobbi M, Salmona M, Nicolas V, Scheper W, Couvreur P, Andrieux K,. 2010. Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic. J Control Release 148 (1): e112-e113.
72. Sun ZK, Yang HQ, Wang ZQ, Pan J, Hong Z, Chen SD,. 2012. Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K/Akt pathway. Transl Neurodegener 1 (1): 7.
73. Ma R, Xiong N, Huang C, Tang Q, Hu B, Xiang J, Li G,. 2009. Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 56 (6-7): 1027-1034.
74. Wang L, Sato H, Zhao S, Tooyama I,. 2010. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Neurosci Lett 481 (3): 164-167.